| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology, Neuromuscular Division, Brigham and Women’s Hospital, and the Children’s Hospital Informatics Program, Children’s Hospital, Harvard Medical School, Boston, MA.
Address correspondence and reprint requests to Dr. Steven A. Greenberg, Department of Neurology, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115; e-mail: sagreenberg{at}partners.org
DNA microarray technology is currently an area of great interest. Also called "genechip" technology, it incorporates molecular genetics and computer science on a massive scale. This technology can rapidly provide a detailed view of the simultaneous expression of entire genomes and provide new insights into gene function, disease pathophysiology, disease classification, and drug development. In this review, the author discusses the basic theory behind genechip and other biologic chip technologies, their limitations given the current state of biologic knowledge and computational abilities, and their potential applications to the understanding of neurologic disorders.
This article has been cited by other articles:
|
|
 |
|
  D. K. Arnett, A. E. Baird, R. A. Barkley, C. T. Basson, E. Boerwinkle, S. K. Ganesh, D. M. Herrington, Y. Hong, C. Jaquish, D. A. McDermott, et al. Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation, June 5, 2007; 115(22): 2878 - 2901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Kissel Muscle biopsy in patients with myalgia: Still a painful decision Neurology, January 16, 2007; 68(3): 170 - 171. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Smolen and J. H. Byrne Support of Progress in Clinical Neurology by Models of Genetic Regulation Arch Neurol, August 1, 2003; 60(8): 1053 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Wicklund and D. Hilton-Jones The limb-girdle muscular dystrophies: Genetic and phenotypic definition of a disputed entity Neurology, April 22, 2003; 60(8): 1230 - 1231. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Noguchi, T. Tsukahara, M. Fujita, R. Kurokawa, M. Tachikawa, T. Toda, A. Tsujimoto, K. Arahata, and I. Nishino cDNA microarray analysis of individual Duchenne muscular dystrophy patients Hum. Mol. Genet., March 15, 2003; 12(6): 595 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Murphy GENE EXPRESSION STUDIES USING MICROARRAYS: PRINCIPLES, PROBLEMS, AND PROSPECTS Advan Physiol Educ, December 1, 2002; 26(4): 256 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Greenberg, D. Sanoudou, J. N. Haslett, I. S. Kohane, L. M. Kunkel, A. H. Beggs, and A. A. Amato Molecular profiles of inflammatory myopathies Neurology, October 22, 2002; 59(8): 1170 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Sergeant, R. J. Large, E. A. H. Beckett, C. M. McGeough, S. M. Ward, and B. Horowitz Microarray comparison of normal and W/Wv mice in the gastric fundus indicates a supersensitive phenotype Physiol Genomics, October 2, 2002; 11(1): 1 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Parmentier-Batteur, K. Jin, L. Xie, X. O. Mao, and D. A. Greenberg DNA Microarray Analysis of Cannabinoid Signaling in Mouse Brain in Vivo Mol. Pharmacol., October 1, 2002; 62(4): 828 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Implications of Microarrays for Clinical Neurology Journal Watch Neurology, March 28, 2002; 2002(328): 10 - 10. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
